Tech Company Financing Transactions
Synbody Biotechnology Funding Round
On 12/10/2012, Synbody Biotechnology raised $250 thousand in financing from Connecticut Innovations.
Transaction Overview
Company Name
Announced On
12/10/2012
Transaction Type
Venture Equity
Amount
$250,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Out of Business
Industry
Biopharmaceutical
Mailing Address
400 Farmington Avenue
Farmington, CT 06032
USA
Farmington, CT 06032
USA
Phone
Website
Email Address
Not Recorded
Overview
Synbody Biotechnology (SBI) is an early stage biotechnology company based on a powerful synthetic antibody, or Synbody The technology was developed at Arizona State University Institute for Biodesign. SBI is based in Farmington, CT
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Paul Hallenbeck
VP - R & D
Kevin Burroughs
Browse more venture capital transactions:
Prev: 12/7/2012: Cloudera venture capital transaction
Next: 12/10/2012: Mycell Technologies venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on funding rounds that are announced publicly. VC transactions reported here come from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs